ACRT Advocacy in the CTSA Era

1
ACRT Advocacy in the CTSA Era

• Current fiscal and political landscape for NIH
• Domenic Ruscio
• Carvarocchi, Ruscio, Dennis Associates, LLC
• Implications of CTSA for ACRT public and local
  advocacy
• Harry Selker, MD
• Chair, ACRT Advocacy Committee
• Discussion
• All

2
ACRT Advocacy in the CTSA Era

• What you see depends on where you stand
• ACRT must have double-vision
• ACRT stands for CR Training
• ACRT stands for full-spectrum translational CR in
  general with other CR organizations

3
CTSA Implications for ACRT and CR

• CTSA in general
• Good (excellent) for CRT, good (excellent) for CR
  in general
• K30 folding into CTSAs
• Good for CRT, good for CR in general
• K12 folding into CTSAs
• Good for CRT, good for CR in general
• T32 folding into CTSAs
• Good for CRT, good for CR in general
• GCRC folding into CTSAs
• Good for CRT, good for CR in general, a challenge
  for GCRCs

4
CTSA Implications for ACRT and CR

• Regulatory
• Good for CRT, good for CR in general
• Translational technologies
• Good for CRT, good for CR in general
• Novel methods
• Good for CRT, good for CR in general
• Informatics
• Good for CRT, good for CR in general
• Governance and culture
• Good (excellent) for CRT, good (excellent) for CR
  in general

5
ACRT Advocacy in the CTSA Era

• Objectives
• Support CTSA via Congress, Administration, NIH
• Follow developments in detail and respond
• Look for common ground with CR community
• Support local/ institutional accomplishment of
  CTSA objectives and proper use of CTSA funds
• Actions
• New Washington representative and continued
  advocacy
• Local advocacy tool set and processes
• Active Advocacy Committee and related activities

6
ACRT Advocacy in the CTSA Era

• Current fiscal and political landscape for NIH
• Domenic Ruscio
• Carvarocchi, Ruscio, Dennis Associates, LLC
• Implications of CTSA for ACRT public and local
  advocacy
• Harry Selker, MD
• Chair, ACRT Advocacy Committee
• Discussion
• All